This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Platinum Releases Statement On Echo Therapeutics Upcoming Annual Meeting

NEW YORK, June 10, 2014 /PRNewswire/ -- Platinum Management (NY) LLC and certain affiliates, the largest stockholder of Echo Therapeutics, Inc., (NasdaqCM: ECTE) ("Echo" or "Company") owning approximately 20% of the common stock, issued the following statement regarding the upcoming June 19 th annual meeting of Echo stockholders:

As we approach June 19 th, we appreciate the supportive comments offered to us by fellow Echo investors in connection with our effort to elect a highly qualified, independent candidate to the Company's Board.  It is particularly gratifying, after Echo management had falsely labeled us as holders whose interests are not aligned with other Echo stockholders, to receive encouragement from our fellow stockholders who have indicated they too are frustrated with the Company's poor performance over the past several years. We trust that Echo stockholders recognize that they have an opportunity NOW to bring positive change to the Company and to the long-term future of their investment through the election of our nominee Shepard M. Goldberg.  We urge stockholders not to be misled by Echo's costly and wasteful proxy campaign, which revolves around the mistaken notion that change is not necessary at Echo. 

Platinum is also pleased to report that recently a leading analyst, LifeTech Capital, observed that Platinum's interests are more closely aligned with Echo stockholders than the current Board's, and recognized the opportunity Echo investors have to affect positive change at the Company on June 19 th.  On May 28 th LifeTech Capital declared:

"Proxy Battle is Last Chance for Investors. Echo Board Remains Tone-Deaf: We note with some irony that after a disastrous 2 years where Echo's stock declined 95% due to multiple poorly executed financings, including an incredibly ill-timed 1 for 10 reverse-split, the Board of Directors is objecting to giving their 20% majority shareholder an additional seat on the board claiming they would not represent all shareholders. Perhaps not, but we believe Platinum Management would represent more shareholders than have been represented in the past. Investors should note that should Platinum fail to gain the board seat at the June 19 th shareholder meeting, it is possible they could sell their shares in the open market further depressing the share price." *

Platinum urges Echo stockholders to vote for change by voting the GOLD proxy card today.  If you have any questions or need assistance, please call Morrow & Co., LLC at 800-662-5200 or (203) 658-9400.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs